Bal Pharma Limited (BALPHARMA) — Net Asset Quality Index
Bal Pharma Limited (BALPHARMA) has a Net Asset Quality Index of 22.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs3.49 Billion minus total liabilities of Rs2.71 Billion yields net assets of Rs783.30 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Bal Pharma Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bal Pharma Limited Net Asset Quality Index Over Time (2006–2025)
This chart shows how Bal Pharma Limited's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the index stands at 22.4%, representing net assets of Rs783.30 Million against total assets of Rs3.49 Billion INR. See BALPHARMA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Bal Pharma Limited (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Bal Pharma Limited from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BALPHARMA market cap.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 23.1% | Rs774.04 Million | Rs3.36 Billion | Rs2.58 Billion | ▲ +1.4 pp |
| 2024 | 21.7% | Rs692.61 Million | Rs3.20 Billion | Rs2.50 Billion | ▲ +1.3 pp |
| 2023 | 20.3% | Rs637.02 Million | Rs3.13 Billion | Rs2.49 Billion | ▼ -2.1 pp |
| 2022 | 22.5% | Rs584.92 Million | Rs2.61 Billion | Rs2.02 Billion | ▲ +0.2 pp |
| 2021 | 22.2% | Rs533.54 Million | Rs2.40 Billion | Rs1.87 Billion | ▲ +3.2 pp |
| 2020 | 19.0% | Rs453.38 Million | Rs2.38 Billion | Rs1.93 Billion | ▼ -4.0 pp |
| 2019 | 23.0% | Rs602.21 Million | Rs2.61 Billion | Rs2.01 Billion | ▼ -0.9 pp |
| 2018 | 23.9% | Rs602.01 Million | Rs2.52 Billion | Rs1.92 Billion | ▼ -2.2 pp |
| 2017 | 26.1% | Rs600.31 Million | Rs2.30 Billion | Rs1.70 Billion | ▲ +0.1 pp |
| 2016 | 25.9% | Rs547.22 Million | Rs2.11 Billion | Rs1.56 Billion | ▼ -7.7 pp |
| 2015 | 33.7% | Rs551.68 Million | Rs1.64 Billion | Rs1.09 Billion | ▲ +1.3 pp |
| 2014 | 32.3% | Rs500.50 Million | Rs1.55 Billion | Rs1.05 Billion | ▲ +2.6 pp |
| 2013 | 29.8% | Rs446.18 Million | Rs1.50 Billion | Rs1.05 Billion | ▲ +1.4 pp |
| 2012 | 28.4% | Rs400.56 Million | Rs1.41 Billion | Rs1.01 Billion | ▲ +1.6 pp |
| 2011 | 26.7% | Rs361.75 Million | Rs1.35 Billion | Rs991.28 Million | ▼ -2.1 pp |
| 2010 | 28.8% | Rs357.62 Million | Rs1.24 Billion | Rs884.40 Million | ▼ -1.8 pp |
| 2009 | 30.6% | Rs372.35 Million | Rs1.22 Billion | Rs843.01 Million | ▼ -1.6 pp |
| 2008 | 32.2% | Rs350.32 Million | Rs1.09 Billion | Rs738.08 Million | ▼ -4.7 pp |
| 2007 | 36.9% | Rs334.02 Million | Rs905.28 Million | Rs571.26 Million | ▲ +0.2 pp |
| 2006 | 36.7% | Rs323.02 Million | Rs881.03 Million | Rs558.01 Million | — |